We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

48 hedge funds and large institutions have $113M invested in Autolus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

4% more funds holding

Funds holding: 46 → 48 (+2)

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

0.4% more ownership

Funds ownership: 23.71% → 24.11% (+0.4%)

21% less capital invested

Capital invested by funds: $142M → $113M (-$29M)

Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
17
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$3.42M
2
EP
Eversept Partners
New York
+$1.65M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$1.14M
4
Morgan Stanley
Morgan Stanley
New York
+$997K
5
JP Morgan Chase
JP Morgan Chase
New York
+$806K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$3.32M
2
GIM
Granahan Investment Management
Massachusetts
-$1.37M
3
Millennium Management
Millennium Management
New York
-$1.25M
4
Two Sigma Investments
Two Sigma Investments
New York
-$386K
5
WMSA
Weiss Multi-Strategy Advisers
New York
-$339K
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$26.4M – – –
TAM
2
TFG Asset Management
Cayman Islands
$19.2M – – –
Schroder Investment Management Group
3
Schroder Investment Management Group
United Kingdom
$15M +$1.14M +107,082 +7%
Capital International Investors
4
Capital International Investors
California
$10.9M – – –
BBA
5
Baker Bros. Advisors
New York
$6.99M +$3.42M +320,859 +70%
AI
6
Alphabet Inc
California
$6.24M – – –
Franklin Resources
7
Franklin Resources
California
$5.1M – – –
GIM
8
Granahan Investment Management
Massachusetts
$4.16M -$1.37M -128,072 -22%
CAM
9
Cormorant Asset Management
Massachusetts
$3.77M – – –
BlackRock
10
BlackRock
New York
$2.68M -$275K -25,830 -8%
JP Morgan Chase
11
JP Morgan Chase
New York
$2.27M +$806K +75,626 +42%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$1.48M -$14.1K -1,327 -0.8%
EP
13
Eversept Partners
New York
$1.39M +$1.65M +154,981 New
Morgan Stanley
14
Morgan Stanley
New York
$1.16M +$997K +93,519 +262%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$1.01M +$626K +58,773 +109%
Renaissance Technologies
16
Renaissance Technologies
New York
$724K +$291K +27,300 +51%
Victory Capital Management
17
Victory Capital Management
Texas
$707K -$139K -13,020 -14%
PG
18
Pendal Group
Australia
$450K +$537K +50,354 New
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$397K +$31.1K +2,917 +7%
MB
20
MPM BioImpact
Massachusetts
$355K – – –
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
$307K -$7.46K -700 -2%
Millennium Management
22
Millennium Management
New York
$276K -$1.25M -117,447 -79%
Wells Fargo
23
Wells Fargo
California
$239K +$110K +10,292 +62%
State Street
24
State Street
Massachusetts
$201K -$18.5K -1,733 -7%
Citadel Advisors
25
Citadel Advisors
Florida
$170K +$60.1K +5,640 +42%
1
2 3

AUTL Hedge Fund Activity: Q4 2020 in Review

48 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q4 2020, worth a combined $113M — down 21% from $142M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AUTL positions and 4 closed out — a net gain of 2 holders — while 17 added to existing stakes and 16 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $3.42M. The largest seller was Artal Group, exiting entirely with an estimated $3.32M sold.

  • 48 institutional investors held Autolus Therapeutics (AUTL) as of Q4 2020, up from 46 in Q3 2020.
  • Funds reported $113M of Autolus Therapeutics stock for Q4 2020, down 21% quarter-over-quarter.
  • 6 funds opened new Autolus Therapeutics positions in Q4 2020 and 4 closed out, a net change of +2 holders.
  • The largest Autolus Therapeutics buyer in Q4 2020 was Baker Bros. Advisors, an estimated $3.42M added.
  • The largest Autolus Therapeutics seller in Q4 2020 was Artal Group, an estimated $3.32M sold.

Based on aggregated 13F filings for Q4 2020.